AIDS: No Way Out


-Mohammad Khairul Alam-
-Executive Director-
-Rainbow Nari O Shishu Kallyan Foudation-
-24/3 M. C. Roy Lane-
-Dhaka-1211, Bangladesh-
-Email: rainbowngo@gmail.com-
-Web: www.newsletter.com.bd-
-Tell: 880-2-8628908-
-Mobile: 88-01711344997-


The epidemics in many countries of South Asia are now entering a new phase. One of the first populations to be affected by HIV in South Asia were injecting drug users. In areas where drug injection has been long established, such as Manipur in north-eastern India, HIV prevalence rates of over 40 percent have been recorded for several years. Several hundred thousand people infected during the explosive start of epidemics are becoming ill and are undergoing treatment. The treatment of infections becomes a great burden for the country concerned, because HIV/AIDS requires long-term and effective medical care, periodical hospital-based care and trained manpower to provide comprehensive healthcare services. For countries where resources are scarce, easy access to treatment and care remain very questionable and prohibitive for many PLWHAs. (people live with HIV/AIDS)


Globally, more or less 40 million people that are infected with HIV/AIDS, Every day 14,000 getting infected and 6,000 are young of them; approximately 95% live in severely resource-constrained settings. In 2005, there were 4.9 million new infected. That means every year add 4.9 million people swap over burden in globally which were potential in the before recent year. If this situation continues there will be burden people increase day by day, and country lost dynamic potential manpower. There is another important argument to take up the challenge: HIV/AIDS mainly affects adults in their productive prime, leaving the very young and old to cope alone. This severely hampers economic growth and development of countries concerned.


Some times poverty facilitates the spread of HIV/AIDS, but equally HIV/AIDS affect poverty. Generalizing HIV/AIDS into a problem of poverty will paralyze an effective and specific response to it. By nature of the population it affects, the economic and developmental impact of HIV/AIDS is likely to be much greater than that of other major infectious diseases or deadly diseases, It is parallel call epidemic other major deadly diseases such as tuberculosis, malaria, diarrhea etc.


Sex workers may be an at-risk population with circumstances and motivations that differ from other high-risk persons. This study shed light on how a person perceives being at risk. Views of ones’ sex partner(s) as the source of risk, rather than one’s own behaviour, appear to affect how people make sense of their sexual activity and decide on protective measures. For sex workers, due to their occupation, these processes induce them to self-identify as being at risk, while other high-risk persons may find denial easier to maintain. However, conditions of their occupation negate sex workers from making those changes most often made by other high-risk persons (fewer partners, monogamy, and consistent condom use). How this relates to getting tested for HIV, and factors that reduce testing differ between male and female sex workers, with economics and access being stronger factors among the female sex workers.


Bangladesh is a high prevalence of sexually transmitted diseases, particularly among commercial sex workers; there are available injection drug users and sex workers all over the country, low condom use in the general population. Considering the high prevalence of HIV risk factors among the Bangladeshi population, HIV prevention research is particularly important for Bangladesh. It is very awful, several organization in Bangladesh are working only to prevent HIV/AIDS but few of them like as ‘Rainbow Nari O Shishu Kallyan Foundation’ try to develop proper strategic plane, so should increase research based organization recently.

Sources: USAID, UNICEF, World Bank

http://www.jnanobiotechnology.com/content/3/1/6

Silver Nanoparticles seem to attach themselves to the active sites of the HIV enzymes that they use to attach themselves to the cells they're trying to infect. The net effect is like dust sticking to tape, preventing the tape from sticking to anything once the dust is stuck to the adhesive.

Silver nanoparticles stick to the active-sites of HIV's enzymes because silver atoms themselves are catalysts, and the nanoclusters are morphologically unstable. Combine those two qualities and you have something that will automatically adapt itself to fit whatever physical distribution of electrical charges it runs across.

From the paper cited, it seems that nanoclusters in the 1 - 10 nanometer ranges seem to stick best to the HIV enzymes.

So, if you want to fight HIV infections, you can either pony-up thousands of dollars per patient per year for conventional therapies, or you can investigate colloidal silver, which is simply nanosilver hydrosol featuring nanoparticles in the 1 - 10 nanometer range. It costs about $75/gallon, and it was approved for human use as a wide-spectrum antibiotic for 75 years. It's recently been demonstrated effective as a wide-spectrum antiviral.

http://www.nanoprotect.co.uk/anti-bacterial-fungi.html

It either works or it doesn't, but it's worth a shot.

-Mohammad Khairul Alam-

Try to have the government of Bangladesh contact the government of Brazil, more precisely the Health Department:
http://portal.saude.gov.br/saude/

Brazil broke the patents for some HIV medicines (I have no details about it since I didn't follow the story) and distributes it free or almost free, and also "sells" it to some countries in Africa (where the word "sell" strictly means that it covers expenses, and is in no way associated with normal commerce, or for-profit activity.

The USA? Didn't want to muss the lobbyist's hairs.